12 November 2017 : Laboratory Research
Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
DOI: 10.12659/MSM.903927
Med Sci Monit 2017; 23:5389-5395
HTML version available soon